MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Coya Therapeutics, Inc. Common Stock

COYA

#3328
Coya Therapeutics, Inc. Common Stock
4.96
+1.22%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
4.96
4.96
Intervallo Annuale
3.94
8.29
Variazione giornaliera
+1.22%
Variazione Mensile
+2.06%
Variazione di 6 mesi
-25.30%
Variazione Annuale
-24.04%
Chiusura Precedente
4.90
Open
4.96
Bid
Ask
Low
4.96
High
4.96
Volume
2
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. COYA
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 202220232024 TTM

Notizie

Investing Investing
RDY COYA
2026.02.02
H.C. Wainwright conferma il rating Buy su Coya Therapeutics con target di $18
Investing Investing
RDY COYA
2026.02.02
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Investing Investing
RDY COYA
2026.01.30
Coya Therapeutics ottiene 11,1 milioni di dollari tramite posizionamento privato
Investing Investing
COYA
2026.01.30
Coya Therapeutics secures $11.1 million in private placement
Investing Investing
COYA
2026.01.20
Coya Therapeutics advances ALS and FTD clinical trials in 2026
Investing Investing
COYA
2026.01.05
H.C. Wainwright conferma rating Buy su Coya Therapeutics con target a $18
Investing Investing
COYA
2026.01.05
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Seeking Alpha Seeking Alpha
GRBK-PA TECK FLR BHF MET-PE
2025.12.15
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
Investing Investing
RDY COYA
2025.12.11
H.C. Wainwright conferma il rating Buy sulle azioni di Coya Therapeutics
Investing Investing
RDY COYA
2025.12.11
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
Investing Investing
COYA
2025.11.24
H.C. Wainwright riconferma il rating Buy sulle azioni di Coya Therapeutics con target di $18
Investing Investing
COYA
2025.11.24
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd